LeonaBio, Inc. Common Stock (LONA) is a publicly traded the market company. As of August 8, 2026, LONA trades at $7.63 with a market cap of $73.36M and a P/E ratio of -4.26. LONA moved +0.77% today. Year to date, LONA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.21 to $14.21. Analyst consensus is strong buy with an average price target of $18.00. Rallies surfaces LONA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LONA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $7.63 |
| Market Cap | $73.36M |
| P/E Ratio | -4.26 |
| EPS | $-1.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.21 |
| 52-Week Low | $4.21 |
| Volume | 34.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-32.95M |
| Gross Margin | 0.00% |
3 analysts cover LONA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.00.